Can Serum C-Reactive Protein/Albumin Ratio be Used as a Marker of Chronic Helicobacter Pylori Infection?

Clinical Laboratory
|January 16, 2026
PubMed
Abstract

Insights

The CRP/albumin ratio (CAR) may indicate Helicobacter pylori infection. Elevated CAR levels were observed in patients with H. pylori, suggesting its potential as a non-invasive biomarker for infection.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Clinical Chemistry

Background:

  • Helicobacter pylori (H. pylori) is a common bacterial cause of gastric inflammation.
  • Current detection methods for H. pylori are often invasive and costly.
  • There is a need for cost-effective, non-invasive biomarkers for H. pylori detection.

Purpose of the Study:

  • To evaluate the CRP/albumin ratio (CAR) as a potential biomarker for H. pylori infection.
  • To assess the correlation between CAR and H. pylori presence and activity.

Main Methods:

  • Retrospective review of medical records from patients undergoing upper gastrointestinal endoscopy.
  • Analysis of laboratory data, including C-reactive protein (CRP) and albumin levels.
  • Statistical analysis using IBM SPSS 27 software.

Main Results:

  • The study included 613 patients; 53.3% tested positive for H. pylori.
  • No significant difference in CRP levels between H. pylori-positive and negative patients.
  • Albumin levels were lower in H. pylori-positive patients (p=0.009).
  • The CAR was significantly elevated in H. pylori-positive patients (p=0.04).

Conclusions:

  • The CRP/albumin ratio (CAR) may serve as a valuable biomarker for H. pylori infection.
  • CAR can potentially reflect the systemic inflammatory status in patients with H. pylori.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
541
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.2K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
365
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K